| A Meta‐Analysis comparing the effectiveness of alternate day fasting, the 5: 2 diet, and Time‐Restricted eating for weight loss P Elortegui Pascual, MR Rolands, AL Eldridge, A Kassis, F Mainardi, ... Obesity 31, 9-21, 2023 | 44 | 2023 |
| A molecular mechanism for Wnt ligand-specific signaling M Eubelen, N Bostaille, P Cabochette, A Gauquier, P Tebabi, AC Dumitru, ... Science 361 (6403), eaat1178, 2018 | 220 | 2018 |
| A randomized controlled clinical trial in healthy older adults to determine efficacy of glycine and N-acetylcysteine supplementation on glutathione redox status and oxidative … G Lizzo, E Migliavacca, D Lamers, A Frézal, J Corthesy, G Vinyes-Parès, ... Frontiers in aging 3, 852569, 2022 | 7 | 2022 |
| Adenosine signaling promotes regeneration of pancreatic β cells in vivo O Andersson, BA Adams, D Yoo, GC Ellis, P Gut, RM Anderson, ... Cell metabolism 15 (6), 885-894, 2012 | 222 | 2012 |
| AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR C Collodet, M Foretz, M Deak, L Bultot, S Metairon, B Viollet, G Lefebvre, ... The FASEB Journal 33 (11), 12374, 2019 | 71 | 2019 |
| An evolutionarily conserved uORF regulates PGC1α and oxidative metabolism in mice, flies, and bluefin tuna PA Dumesic, DF Egan, P Gut, MT Tran, A Parisi, N Chatterjee, ... Cell metabolism 30 (1), 190-200. e6, 2019 | 47 | 2019 |
| Author response: MondoA regulates gene expression in cholesterol biosynthesis-associated pathways required for zebrafish epiboly M Weger, BD Weger, A Schink, M Takamiya, J Stegmaier, C Gobet, ... | | |
| BRIEF CUTTING EDGE REPORTS ENC Manoogian, B Laferrère, PE Pascual, MR Rolands, AL Eldridge, ... | | 2023 |
| Chemical genetic screen identifies Gapex-5/GAPVD1 and STBD1 as novel AMPK substrates S Ducommun, M Deak, A Zeigerer, O Göransson, S Seitz, C Collodet, ... Cellular signalling 57, 45-57, 2019 | 31 | 2019 |
| Compositions and methods containing reduced nicotinamide riboside for prevention and treatment of cardiovascular diseases and conditions CC Alvarez, S Christen, MP Giner, J Giroud-Gerbetant, M Sofia, ... | | 2021 |
| Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids J Feige, P Gut, G Civiletto, C Boutry US Patent App. 17/596,784, 2022 | | 2022 |
| Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids on bone health J Feige, P Gut, G Civiletto, C Boutry US Patent App. 17/686,054, 2022 | | 2022 |
| Compositions and methods using a combination of autophagy inducer and high protein for induction of autophagy G Civiletto, B Cuenoud, J Feige, P Gut US Patent App. 18/199,523, 2023 | | 2023 |
| Compositions and methods using a combination of autophagy inducer and high protein for induction of autophagy G Civiletto, B Cuenoud, J Feige, P Gut US Patent App. 16/954,694, 2021 | | 2021 |
| Compositions and methods using at least one glycine or derivative thereof and at least one large neutral amino acid and/or cationic amino acid or precursor thereof G Lizzo, P Gut US Patent App. 18/256,489, 2024 | | 2024 |
| Compositions and methods using at least one glycine or derivative thereof, at least one n-acetylcysteine or derivative thereof, and at least one nicotinamide riboside or nad+ … P Gut, S Blum-Sperisen, G Lizzo US Patent App. 18/519,667, 2024 | | 2024 |
| Compositions and methods using at least one glycine or derivative thereof, at least one N-acetylcysteine or derivative thereof, and at least one nicotinamide riboside or NAD+ … P Gut, S Blum-Sperisen, G Lizzo US Patent 11,974,975, 2024 | | 2024 |
| Compositions and methods using high protein for induction of autophagy G Civiletto, B Cuenoud, J Feige, P Gut US Patent App. 16/954,696, 2020 | | 2020 |
| Compositions and methods using one or more autophagy-inducing amino acids to potentiate musculoskeletal effect of one or more anabolic amino acids J Feige, P Gut, G Civiletto, C Boutry US Patent App. 17/596,144, 2022 | 1 | 2022 |
| Compositions and methods using thymol and/or carvacrol for induction of autophagy J Feige, P Gut, G Civiletto, F Sizzano US Patent App. 17/596,779, 2022 | | 2022 |
Eric VerdinCEO & President, Buck Institute for Research on Aging在 buckinstitute.org 的电子邮件经过验证
